Frequencies of CD14+ TSLP receptor–positive expressing monocytes responded to DMSO sensitization in NSG-AD mice, and a significant difference was observed between the respective control groups (AD control vs AD DMSO: P = .005; AD control vs PV control: P = .004; AD DMSO vs PV DMSO: P = .09, Wilcoxon rank sum test with continuity correction). This evidence concerns the gene CD14 and Alzheimer disease.